In this episode, Don Webber, CEO and Mauricio Carvalho, VP of Medical & Scientific Affairs at Bridge to Life unpack the urgent challenge behind transplant medicine: outcomes are strong, but organ availability and perceived risk keep waiting lists high. Expanding the donor pool requires new preservation and assessment tools, and they explain how Bridge to Life is advancing hypothermic and perfusion-based organ preservation to protect cells, improve viability assessment, and help match organs to recipients with more objective biological insights. Mauricio shares hard-earned lessons bringing technology from Europe to the U.S. (where reimbursement, procurement, workflows, and contracting add layers that can make or break adoption) captured in the theme “science can be global, but implementation is local.” Don details Bridge to Life’s evolution, Series C $110M raise, and why adoption is earned through evidence, simplicity, economics, and deep onsite clinical support.
Podden och tillhörande omslagsbild på den här sidan tillhör
Project Medtech. Innehållet i podden är skapat av Project Medtech och inte av,
eller tillsammans med, Poddtoppen.
